Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Irritable Bowel Syndrome (IBS) Market 2018, Forecast to 2023

December 2018 | 134 pages | ID: G28416A03FDEN
GlobalInfoResearch

Abstracts

Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.

Scope of the Report:

This report focuses on the Irritable Bowel Syndrome (IBS) in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Currently, the IBS treatment market is naïve and underpenetrated, with 4 products indicated for IBS in the market. These include the IBS-C therapies, Amitiza (lubiprostone, Sucampo/Takeda) and Linzess (linaclotide, Ironwood/Allergan/Astellas); and the IBS-D therapies, Lotronex (Sebela Pharmaceuticals) and Irribow (ramosetron, Astellas). Antidepressants and antibiotics (mainly Xifaxan [rifaximin], Valeant) are also used off-label to treat IBS.
The IBS treatment market is characterized by significant unmet needs, which include the need for products with improved efficacy, products for the treatment of the IBS-D and IBS-M subtypes, and products that effectively address IBS symptoms, such as abdominal pain and bloating, as well as the requirement for the improved diagnosis of IBS. As a result, there are significant opportunities in the uncrowded IBS therapeutics market.
The worldwide market for Irritable Bowel Syndrome (IBS) is expected to grow at a CAGR of roughly 16.3% over the next five years, will reach 6530 million US$ in 2023, from 2640 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Allergan
• Valeant Pharmaceuticals
• Takeda
• Sucampo Pharmaceuticals
• McNeil Consumer Healthcare
• Sebela Pharmaceuticals
• Astellas Pharmaceuticals
• IM HealthScience

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• IBS-D Drug
• IBS-C Drug
• Other

Market Segment by Applications, can be divided into

• Women
• Men

There are 15 Chapters to deeply display the global Irritable Bowel Syndrome (IBS) market.

Chapter 1, to describe Irritable Bowel Syndrome (IBS) Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Irritable Bowel Syndrome (IBS), with sales, revenue, and price of Irritable Bowel Syndrome (IBS), in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Irritable Bowel Syndrome (IBS), for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Irritable Bowel Syndrome (IBS) market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Irritable Bowel Syndrome (IBS) sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Irritable Bowel Syndrome (IBS) Introduction
1.2 Market Analysis by Type
  1.2.1 IBS-D Drug
  1.2.2 IBS-C Drug
  1.2.3 Other
1.3 Market Analysis by Applications
  1.3.1 Women
  1.3.2 Men
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Allergan
  2.1.1 Business Overview
    2.1.1.1 Allergan Description
    2.1.1.2 Allergan Headquarter, Main Business and Finance Overview
  2.1.2 Allergan Irritable Bowel Syndrome (IBS) Product Introduction
    2.1.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.1.3 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Allergan Irritable Bowel Syndrome (IBS) Market Share in 2017
2.2 Valeant Pharmaceuticals
  2.2.1 Business Overview
    2.2.1.1 Valeant Pharmaceuticals Description
    2.2.1.2 Valeant Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.2.2 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Introduction
    2.2.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.2.3 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share in 2017
2.3 Takeda
  2.3.1 Business Overview
    2.3.1.1 Takeda Description
    2.3.1.2 Takeda Headquarter, Main Business and Finance Overview
  2.3.2 Takeda Irritable Bowel Syndrome (IBS) Product Introduction
    2.3.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.3.3 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Takeda Irritable Bowel Syndrome (IBS) Market Share in 2017
2.4 Sucampo Pharmaceuticals
  2.4.1 Business Overview
    2.4.1.1 Sucampo Pharmaceuticals Description
    2.4.1.2 Sucampo Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.4.2 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Introduction
    2.4.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.4.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share in 2017
2.5 McNeil Consumer Healthcare
  2.5.1 Business Overview
    2.5.1.1 McNeil Consumer Healthcare Description
    2.5.1.2 McNeil Consumer Healthcare Headquarter, Main Business and Finance Overview
  2.5.2 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product Introduction
    2.5.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.5.3 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Market Share in 2017
2.6 Sebela Pharmaceuticals
  2.6.1 Business Overview
    2.6.1.1 Sebela Pharmaceuticals Description
    2.6.1.2 Sebela Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.6.2 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Introduction
    2.6.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.6.3 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share in 2017
2.7 Astellas Pharmaceuticals
  2.7.1 Business Overview
    2.7.1.1 Astellas Pharmaceuticals Description
    2.7.1.2 Astellas Pharmaceuticals Headquarter, Main Business and Finance Overview
  2.7.2 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product Introduction
    2.7.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.7.3 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Market Share in 2017
2.8 IM HealthScience
  2.8.1 Business Overview
    2.8.1.1 IM HealthScience Description
    2.8.1.2 IM HealthScience Headquarter, Main Business and Finance Overview
  2.8.2 IM HealthScience Irritable Bowel Syndrome (IBS) Product Introduction
    2.8.2.1 Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Irritable Bowel Syndrome (IBS) Product Information
  2.8.3 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global IM HealthScience Irritable Bowel Syndrome (IBS) Market Share in 2017

3 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET COMPETITION, BY MANUFACTURER

3.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Irritable Bowel Syndrome (IBS) Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2017
  3.4.2 Top 5 Irritable Bowel Syndrome (IBS) Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET ANALYSIS BY REGIONS

4.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Regions
  4.1.1 Global Irritable Bowel Syndrome (IBS) Sales by Regions (2013-2018)
  4.1.2 Global Irritable Bowel Syndrome (IBS) Revenue by Regions (2013-2018)
4.2 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  5.1.1 North America Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
  5.1.2 North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
  5.1.3 United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  5.1.4 Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
5.2 North America Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2017)
  5.2.2 North America Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2017)
5.3 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Irritable Bowel Syndrome (IBS) Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2013-2018)
5.4 North America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Irritable Bowel Syndrome (IBS) Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Application (2013-2018)

6 EUROPE IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  6.1.1 Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
  6.1.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
  6.1.3 Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  6.1.4 UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  6.1.5 France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  6.1.6 Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  6.1.7 Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
6.2 Europe Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2017)
  6.2.2 Europe Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2017)
6.3 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Irritable Bowel Syndrome (IBS) Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Irritable Bowel Syndrome (IBS) Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
  7.1.3 China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  7.1.4 Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  7.1.5 Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  7.1.6 India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  8.1.1 South America Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
  8.1.2 South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
  8.1.3 Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
8.2 South America Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2017)
  8.2.2 South America Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2017)
8.3 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Irritable Bowel Syndrome (IBS) Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2013-2018)
8.4 South America Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Irritable Bowel Syndrome (IBS) Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA IRRITABLE BOWEL SYNDROME (IBS) BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  9.1.4 UAE Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENT BY TYPE

10.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Irritable Bowel Syndrome (IBS) Sales and Market Share by Type (2013-2018)
  10.1.2 Global Irritable Bowel Syndrome (IBS) Revenue and Market Share by Type (2013-2018)
10.2 IBS-D Drug Sales Growth and Price
  10.2.1 Global IBS-D Drug Sales Growth (2013-2018)
  10.2.2 Global IBS-D Drug Price (2013-2018)
10.3 IBS-C Drug Sales Growth and Price
  10.3.1 Global IBS-C Drug Sales Growth (2013-2018)
  10.3.2 Global IBS-C Drug Price (2013-2018)
10.4 Other Sales Growth and Price
  10.4.1 Global Other Sales Growth (2013-2018)
  10.4.2 Global Other Price (2013-2018)

11 GLOBAL IRRITABLE BOWEL SYNDROME (IBS) MARKET SEGMENT BY APPLICATION

11.1 Global Irritable Bowel Syndrome (IBS) Sales Market Share by Application (2013-2018)
11.2 Women Sales Growth (2013-2018)
11.3 Men Sales Growth (2013-2018)

12 IRRITABLE BOWEL SYNDROME (IBS) MARKET FORECAST (2018-2023)

12.1 Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2018-2023)
12.2 Irritable Bowel Syndrome (IBS) Market Forecast by Regions (2018-2023)
  12.2.1 North America Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
  12.2.2 Europe Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
  12.2.4 South America Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
12.3 Irritable Bowel Syndrome (IBS) Market Forecast by Type (2018-2023)
  12.3.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2018-2023)
  12.3.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2018-2023)
12.4 Irritable Bowel Syndrome (IBS) Market Forecast by Application (2018-2023)
  12.4.1 Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2018-2023)
  12.4.2 Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Irritable Bowel Syndrome (IBS) Picture
Table Product Specifications of Irritable Bowel Syndrome (IBS)
Figure Global Irritable Bowel Syndrome (IBS) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Irritable Bowel Syndrome (IBS) CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Irritable Bowel Syndrome (IBS) by Types in 2017
Figure IBS-D Drug Picture
Table Major Manufacturers of IBS-D Drug
Figure IBS-C Drug Picture
Table Major Manufacturers of IBS-C Drug
Figure Other Picture
Table Major Manufacturers of Other
Figure Irritable Bowel Syndrome (IBS) Sales Market Share by Applications in 2017
Figure Women Picture
Figure Men Picture
Figure United States Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure France Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure UK Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure China Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure India Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Irritable Bowel Syndrome (IBS) Revenue (Value) and Growth Rate (2013-2023)
Table Allergan Headquarter, Established, Main Business and Finance Overview (2017)
Table Allergan Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Allergan Irritable Bowel Syndrome (IBS) Product
Table Allergan Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Allergan Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Allergan Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Valeant Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Valeant Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Takeda Headquarter, Established, Main Business and Finance Overview (2017)
Table Takeda Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Takeda Irritable Bowel Syndrome (IBS) Product
Table Takeda Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Takeda Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Takeda Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Sucampo Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Sucampo Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table McNeil Consumer Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Product
Table McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global McNeil Consumer Healthcare Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Sebela Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Sebela Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Astellas Pharmaceuticals Headquarter, Established, Main Business and Finance Overview (2017)
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Product
Table Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global Astellas Pharmaceuticals Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table IM HealthScience Headquarter, Established, Main Business and Finance Overview (2017)
Table IM HealthScience Irritable Bowel Syndrome (IBS) Production Bases, Sales Regions and Major Competitors
Table IM HealthScience Irritable Bowel Syndrome (IBS) Product
Table IM HealthScience Irritable Bowel Syndrome (IBS) Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global IM HealthScience Irritable Bowel Syndrome (IBS) Sales Market Share in 2017
Figure Global IM HealthScience Irritable Bowel Syndrome (IBS) Revenue Market Share in 2017
Table Global Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table Global Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table Global Irritable Bowel Syndrome (IBS) Price by Manufacturer (2016-2017)
Figure Top 3 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Irritable Bowel Syndrome (IBS) Manufacturer (Revenue) Market Share in 2017
Figure Global Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Regions (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales Market Share by Regions (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Regions (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2013
Figure Global Irritable Bowel Syndrome (IBS) Revenue Market Share by Regions in 2017
Figure North America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2013
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2017
Table North America Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2013-2018)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2013
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2017
Figure United States Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Canada Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Mexico Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure North America Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table North America Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure North America Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table North America Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Revenue by Application (2013-2018)
Table North America Irritable Bowel Syndrome (IBS) Revenue Share by Application (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2016
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2017
Figure Germany Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure UK Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure France Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Russia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Italy Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure Europe Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure Europe Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table Europe Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Revenue by Application (2013-2018)
Table Europe Irritable Bowel Syndrome (IBS) Revenue Share by Application (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Countries 2017
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries 2017
Figure China Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Japan Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Korea Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure India Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Southeast Asia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue by Application (2013-2018)
Table Asia-Pacific Irritable Bowel Syndrome (IBS) Revenue Share by Application (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2017
Table South America Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2013-2018)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2017
Figure Brazil Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Argentina Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Colombia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure South America Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure South America Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table South America Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure South America Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table South America Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Revenue by Application (2013-2018)
Table South America Irritable Bowel Syndrome (IBS) Revenue Share by Application (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Countries (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Countries in 2017
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Countries (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2013
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Countries in 2017
Figure Saudi Arabia Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure UAE Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Egypt Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure Nigeria Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Figure South Africa Irritable Bowel Syndrome (IBS) Sales and Growth Rate (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue by Application (2013-2018)
Table Middle East and Africa Irritable Bowel Syndrome (IBS) Revenue Share by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue by Type (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Revenue Share by Type (2013-2018)
Figure Global IBS-D Drug Sales Growth (2013-2018)
Figure Global IBS-D Drug Price (2013-2018)
Figure Global IBS-C Drug Sales Growth (2013-2018)
Figure Global IBS-C Drug Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales by Application (2013-2018)
Table Global Irritable Bowel Syndrome (IBS) Sales Share by Application (2013-2018)
Figure Global Women Sales Growth (2013-2018)
Figure Global Men Sales Growth (2013-2018)
Figure Global Irritable Bowel Syndrome (IBS) Sales, Revenue and Growth Rate (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Regions (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Regions (2018-2023)
Figure North America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
Figure Europe Sales Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
Figure Asia-Pacific Sales Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
Figure South America Sales Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
Figure Middle East and Africa Sales Irritable Bowel Syndrome (IBS) Market Forecast (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Type (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Sales Forecast by Application (2018-2023)
Table Global Irritable Bowel Syndrome (IBS) Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List